GE HealthCare Technologies (GEHC) is back in focus after securing 510(k) FDA clearance for three MRI offerings, including a helium free system, a high performance 3T scanner and an AI centered workflow platform.

Despite the fresh MRI clearances and a series of recent agreements in ultrasound, imaging alliances and new credit facilities, GE HealthCare’s recent momentum has been mixed, with a 1 month share price return of 1.51% but a 1 year total shareholder return decline of 7.11%.

If this MRI news has you thinking more broadly about medical technology, it could be a good moment to scan our screener of 28 healthcare AI stocks for more healthcare names using AI in meaningful ways.

GE HealthCare now trades around $80, with an implied intrinsic discount of about 31% and a value score of 5, yet recent returns have been soft. Is this a reset that leaves potential upside on the table, or is the market already pricing in future growth?

Most Popular Narrative: 14% Undervalued

At a last close of $80.16 against a most-followed fair value of $93.25, the narrative sees material upside rooted in steady execution and capital discipline.

The pipeline of new high-impact products, like Radiopharmaceuticals, Total Body PET, and Photon Counting CT, is anticipated to drive future revenue growth and potentially improve margins.

The focus on expanding recurring revenue, particularly in areas like digital solutions and advanced visualization, is expected to contribute positively to revenue stability and net margins.

For readers interested in the growth path and margin profile underlying that fair value, as well as how a future earnings multiple connects those assumptions, the full narrative presents the details in plain numbers.

Result: Fair Value of $93.25 (UNDERVALUED)

However, the story can change quickly if tariff costs bite harder than expected or if competitors gain ground in key imaging and diagnostics markets.

Next Steps

If the mix of upside and caution here feels finely balanced, consider acting while the data is fresh and weighing it for yourself with 4 key rewards and 1 important warning sign.

Looking for more investment ideas?

If GE HealthCare has sharpened your interest, do not stop here, use the Simply Wall St Screener to spot other opportunities that could fit your style.

• Target value plays that balance quality and price by scanning our list of 45 high quality undervalued stocks built from detailed fundamentals.
• Anchor your portfolio with companies that prioritize financial strength by checking out the solid balance sheet and fundamentals stocks screener (41 results) that pass our balance sheet tests.
• Get ahead of the crowd by reviewing a screener containing 24 high quality undiscovered gems that the market may not be paying close attention to yet.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.